WallStSmart
OCGN

Ocugen Inc

NASDAQ: OCGN · HEALTHCARE · BIOTECHNOLOGY

$1.73
+2.98% today

Updated 2026-04-30

Market cap
$557.42M
P/E ratio
P/S ratio
126.31x
EPS (TTM)
$-0.23
Dividend yield
52W range
$1 – $3
Volume
8.9M

Ocugen Inc (OCGN) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+0.3%
Last 4 quarters
Revenue YoY growth
-125.3%
Most recent quarter
EPS YoY growth
-20.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-7.1%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-10.7%
2026-03-27
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-27$-0.06-7.1%$1.96$1.75-10.7%
2025-11-05$-0.07-25.0%$1.43$1.38-3.5%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.06$-0.06-7.1%$-193000.00-125.3%
2025-09-30$-0.06$-0.07-25.0%$1.75M+54.2%
2025-06-30$-0.06$-0.05+16.7%$1.37M+20.3%
2025-03-31$-0.06$-0.05+16.7%$1.48M+46.1%
2024-12-31$-0.05$-0.05+6.2%$764000.00-87.3%
2024-09-30$-0.05$-0.05+0.0%$1.14M-69.3%
2024-06-30$-0.05$-0.04+20.0%$1.14M+135.3%
2024-03-31$-0.06$-0.05+16.7%$1.01M+128.9%
2023-12-31$-0.06$-0.03+50.0%$6.04M
2023-09-30$-0.07$-0.06+14.3%$3.70M
2023-06-30$-0.07$-0.08-14.3%$485000.00
2023-03-31$-0.11$-0.07+36.4%$443000.00

Frequently asked questions

Has Ocugen Inc beaten earnings estimates?
Ocugen Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +0.3% over the last 4 quarters.
How does OCGN stock react to earnings?
OCGN stock has moved an average of -7.1% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Ocugen Inc's revenue growth rate?
Ocugen Inc reported year-over-year revenue growth of -125.3% in its most recent quarter, with EPS growing -20.0% year-over-year.